Jong-Hwa Park
Director/Board Member bei CLINOMICS INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Jong-Hwa Park is currently the Chief Executive Officer at Geromics, Inc. and the Director at Clinomics, Inc. He has an undergraduate degree from the University of Aberdeen and a doctorate degree from the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CLINOMICS, INC.
7,38% | 30.04.2024 | 2 453 373 ( 7,38% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Jong-Hwa Park
| Unternehmen | Position | Beginn |
|---|---|---|
| CLINOMICS INC. | Director/Board Member | 01.09.2018 |
Geromics, Inc.
 Geromics, Inc. Miscellaneous Commercial ServicesCommercial Services Geromics, Inc. engages in the research and development of bio technologies. Its services include bio information technology, genetic test, life science research support, and others. The company was founded on November 18, 2014 and is headquartered in Ulsan, South Korea. | Chief Executive Officer | - |
Ausbildung von Jong-Hwa Park
| University of Aberdeen | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLINOMICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Geromics, Inc.
Geromics, Inc. Miscellaneous Commercial ServicesCommercial Services Geromics, Inc. engages in the research and development of bio technologies. Its services include bio information technology, genetic test, life science research support, and others. The company was founded on November 18, 2014 and is headquartered in Ulsan, South Korea. | Commercial Services |
